Expression of vascular endothelial growth factor A, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas

Ophthalmic Research

Volumn 39, Issue 1, 2007, Pages 40-44

  Sahin, Afsun ^a   Kiratli, Hayyam ^a   Tezel, Gaye Guler ^a   Soylemezoglu, Figen ^a   Bilgic, Sevgul ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Extravascular matrix patterns; Immunohistochemistry; Iris and ciliary body melanomas; Matrix metalloproteinase; Vascular endothelial growth factor

Indexed keywords

EOSIN; GELATINASE B; HEMATOXYLIN; PARAFFIN; VASCULOTROPIN A;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CELL TYPE; CILIARY ARTERY; CILIARY BODY TUMOR; CLINICAL ARTICLE; CORRELATION ANALYSIS; EPITHELIOID CELL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IRIS BLOOD VESSEL; IRIS TUMOR; LYMPHOCYTIC INFILTRATION; MALE; MELANOMA; MICROSCOPY; MICROVASCULATURE; MITOSIS INDEX; MITOSIS RATE; NECROSIS; PIGMENTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERA; SPINDLE CELL; TISSUE SECTION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; CILIARY BODY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IRIS NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846257134     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097905     Document Type: Article

References (21)

1. Yap-Veloso MI, Simmons RB, Simmons RJ: Iris melanoma: diagnosis and management. Int Ophthalmol Clin 1997;37:87-101.
2. Jensen OA: Malignant melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol (Copenh) 1970;48:1113-1128.
3. Rones B, Zimmerman LE: The prognosis of primary tumors of the iris treated by iridectomy. Arch Ophthalmol 1958;60:193-205.
4. Geisse LJ, Robertson DM: Iris melanomas. Am J Ophthalmol 1985;99:638-648.
5. Shields CL, Shields JA, Materin M, Gershenbaum E, Singh AD, Smith A: Iris melanoma. Risk factors for metastasis in 169 consecutive patients. Ophthalmology 2001;108:172-178.
6. Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, Moninger TO, Yi H, Moore KC: The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 1992;23:1298-1305.
7. Coomber BL, Yu JL, Fathers KE, Plumb C, Rak JW: Angiogenesis and the role of epigenetics in metastasis. Clin Exp Metastasis 2003;20:215-227.
8. Detmar M: Tumor angiogenesis. J Investig Dermatol Symp Proc 2000;5:20-23.
9. Schlingemann RO, van Hinsbergh VW: Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol 1997;81:501-512.
10. John A, Tuszynski G: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001;7:14-23.
11. Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-1270.
12. Boyd SR, Tan DS, de Souza L, Neale MH, Myatt NE, Alexander RA, Robb M, Hungerford JL, Cree IA: Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth. Br J Ophthalmol 2002;86:440-447.
13. Sheidow TG, Hooper PL, Crukley C, Young J, Heathcote JG: Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. Br J Ophthalmol 2000;84:750-756.
14. Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V, Hendrix MJ: Cooperative interactions of laminin 5 γ2 chain, matrix metalloproteinase-2, and membrane type-1 matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001;61:6322-6327.
15. Rao RA, et al: Matrix metalloproteinases in uveal malignant melanoma: computer-based morphometric analysis (E-abstract). Invest Ophthalmol Vis Sci 2004;45:1198.
16. Folberg R, Rummelt V, Parys-Van GR, et al: The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100:1389-1398.
17. Maniotis AJ, Folberg R, Hess A, et al: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155:739-752.
18. Folberg R, Hendrix MJC, Maniotis AJ: Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000;156:361-381.
19. Rummelt V, Folberg R, Rummelt C, et al: Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study. Ophthalmology 1994;101:718-727.
20. Chowers I, Folberg R, Livni N, Pe'er J: Comparison of microcirculation patterns and MIB-1 immunoreactivity in iris and posterior uveal melanoma. Ophthalmology 2001;108:367-371.
21. Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3. Basel, Karger, 1996, pp 38-55.